loading
logo

ΚαλωσήρθατεΑναστασιος Γ. Κριεμπαρδης

Κατεβαστε το Βιογραφικο μου Συντομο Βιογραφικο

ΕΠΙΣΤΗΜΟΝΙΚΕΣ ΔΗΜΟΣΙΕΥΣΕΙΣ ΣΕ ΔΙΕΘΝΗ ΠΕΡΙΟΔΙΚΑ ΜΕ ΚΡΙΤΕΣ

  1. Unveiling the impact of the COVID-19 pandemic on blood donation patterns: A Greek perspective.Fortis SP, Dryllis G, Anastasiadi AT, Tzounakas VL, Konstantakopoulou O, Georgatzakou HT, Pavlou EG, Tsantes AG, Theodorogianni V, Kosma MA, Papageorgiou EG, Stamoulis KE, Beloukas A, Politou M, Valsami S, Kriebardis AG. Transfus Apher Sci. 2025 Apr 24;64(3):104122.
  2. The ABO Blood System and Associated Implications for Hemostasis and Thrombosis. Petrou E, Donta AM, Mellou S, Tsalas S, Tsantes AG, Bethanis DA, Kriebardis AG, Kyriakou E, Sokou R, Tsantes AE. Semin Thromb Hemost. 2025 Apr 16.
  3. Synovial Fibroblast Extracellular Vesicles Induce Inflammation via Delivering miR-21-5p in Osteoarthritis. Konteles V, Papathanasiou I, Tzetis M, Kriebardis AG, Tsezou A. Cells. 2025 Mar 31;14(7):519.
  4. Cold vs. Room Temperature: A Comparative Analysis of Platelet Functionality in Cold Storage. Drossos PV, Fortis SP, Anastasiadi AT, Pavlou EG, Tsantes AG, Spyratos GA, Papageorgiou EG, Nomikou EG, Stamoulis KE, Dryllis G, Tzounakas VL, Politou M, Valsami S, Kriebardis AG. 2025 Jan 27;13(2):310.
  5. Morphogens and Cell-Derived Structures (Exosomes and Cytonemes) as Components of the Communication Between Cells. Chideriotis S, Anastasiadi AT, Tzounakas VL, Fortis SP, Kriebardis AG, Valsami S. Int J Mol Sci. 2025 Jan 21;26(3):881.
  6. Thromboelastometry-Based Profiling of Haemostatic Alterations in Neonatal Sepsis by Causative Pathogens. Sokou R, Gounari EA, Tsante KA, Konstantinidi A, Lampridou M, Theodoraki M, Kriebardis AG, Fortis SP, Iacovidou N, Tsantes AG. Antibiotics (Basel). 2025 Jan 17;14(1):101.
  7. Transfusion-associated graft-versus-host disease (TA-GVHD) and graft-versus-host disease (GVHD): Pathophysiology and management (contrasted and compared). Valsami S, Dryllis G, Papanastasi K, Kokoris S, Kriebardis AG, Nikitiadis K, Konstantopoulos K, Politou M. Hematol Oncol Stem Cell Ther. 2024 Oct-Dec 01;17(4):203-210.
  8. Development of Alginate Hydrogels Incorporating Essential Oils Loaded in Chitosan Nanoparticles for Biomedical Applications. Pitterou I, Kalogeropoulou F, Tzani A, Tsiantas K, Gatou MA, Pavlatou E, Batrinou A, Fountzoula C, Kriebardis AG, Zoumpoulakis P, Detsi A. Molecules. 2024 Nov 12;29(22):5318.
  9. Molecular modifications to mitigate oxidative stress and improve red blood cell storability. Anastasiadi AT, Stamoulis K, Kriebardis AG, Tzounakas VL. Front Physiol. 2024 Oct 30;15:1499308.
  10. Assessment of metabolic and hemostatic profile of apheresis platelet concentrates: does the storage medium play a role? Petrou E, Tsalas S, Tsantes AG, Loukopoulou E, Mellou S, Fortis SP, Rapti E, Sokou R, Kyriakou E, Douramani P, Frantzeskaki F, Samonis G, Kokoris S, Kriebardis AG, Tsantes AE. Blood Transfus. 2024 Nov;22(6):492-501.
  11. Precision Oncology: Circulating Microvesicles as New Biomarkers in a Very Early Stage of Colorectal Cancer. Kriebardis AG, Chardalias L, Damaskos C, Pouliakis A, Garmpis N, Fortis SP, Papailia A, Sideri C, Georgatzakou HT, Papageorgiou EG, Pittaras T, Tsourouflis G, Politou M, Papaconstantinou I, Dimitroulis D, Valsami S. Cancers (Basel). 2024 May 20;16(10):1943.
  12. Exploring Aggressive Behaviors in Greek Secondary Schools: Prevalence, Sociodemographic Factors, and Comparative Analysis with Elementary School Students. Bourou A, Karkalousos P, Kriebardis AG, Papageorgiou E. Behav Sci (Basel). 2024 May 13;14(5):405.
  13. A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment. Trifylli EM, Kriebardis AG, Koustas E, Papadopoulos N, Fortis SP, Tzounakas VL, Anastasiadi AT, Sarantis P, Vasileiadi S, Tsagarakis A, Aloizos G, Manolakopoulos S, Deutsch M. Int J Mol Sci. 2024 Mar 17;25(6):3406.
  14. The effects of pathogen reduction technology on apheresis platelet concentrates stored in PAS. Tsalas S, Tsantes AG, Petrou E, Mellou S, Sokou R, Loukopoulou E, Kriebardis AG, Fortis SP, Papadopoulos DV, Vaiopoulos AG, Kokoris S, Tsantes AE. Blood Transfus. 2024 Sep;22(5):405-414.
  15. Exploring unconventional attributes of red blood cells and their potential applications in biomedicine. Anastasiadi AT, Arvaniti VZ, Hudson KE, Kriebardis AG, Stathopoulos C, D’Alessandro A, Spitalnik SL, Tzounakas VL. Protein Cell. 2024 May 7;15(5):315-330.
  16. Stratification of βSβ+ Compound Heterozygotes Based on L-Glutamine Administration and RDW: Focusing on Disease Severity. Giannaki A, Georgatzakou HΤ, Fortis SP, Anastasiadi AT, Pavlou EG, Nomikou EG, Drandaki MP, Kotsiafti A, Xydaki A, Fountzoula C, Papageorgiou EG, Tzounakas VL, Kriebardis AG. Antioxidants (Basel). 2023 Nov 8;12(11):1982.
  17. The Arising Role of Extracellular Vesicles in Cholangiocarcinoma: A Rundown of the Current Knowledge Regarding Diagnostic and Therapeutic Approaches. Trifylli EM, Kriebardis AG, Koustas E, Papadopoulos N, Vasileiadi S, Fortis SP, Tzounakas VL, Anastasiadi AT, Sarantis P, Papageorgiou EG, Tsagarakis A, Aloizos G, Manolakopoulos S, Deutsch M. Int J Mol Sci. 2023 Oct 25;24(21):15563.
  18. Effect of silica-based mesoporous nanomaterials on human blood cells. Fortis SP, Batrinou A, Georgatzakou HT, Tsamesidis I, Alvanidis G, Papageorgiou EG, Stamoulis K, Gkiliopoulos D, Pouroutzidou GK, Theocharidou A, Kontonasaki E, Kriebardis AG. Chem Biol Interact. 2024 Jan 5;387:110784.
  19. MFGE-8 identified in fetal mesenchymal-stromal-cell-derived exosomes ameliorates acute hepatic failure pathology. Psaraki A, Zagoura D, Ntari L, Makridakis M, Nikokiraki C, Trohatou O, Georgila K, Karakostas C, Angelioudaki I, Kriebardis AG, Gramignioli R, Sakellariou S, Xilouri M, Eliopoulos AG, Vlahou A, Roubelakis MG. iScience. 2023 Sep 30;26(11):108100.
  20. A Pilot Observational Study Evaluating the Diagnostic Capacity of Rotational Thromboelastometry in Periprosthetic Joint Infections. Tsantes AG, Papadopoulos DV, Goumenos S, Trikoupis IG, Tsante KA, Bellou V, Koulouvaris P, Houhoula D, Kriebardis AG, Piovani D, Nikolopoulos GK, Mavrogenis AF, Papagelopoulos PJ, Bonovas S, Tsantes AE. J Bone Joint Surg Am. 2023 Dec 20;105(24):1980-1986.
  21. Endogenous Alpha-Synuclein is Essential for the Transfer of Pathology by Exosome-Enriched Extracellular Vesicles, Following Inoculation with Preformed Fibrils in vivo. Melachroinou K, Divolis G, Tsafaras G, Karampetsou M, Fortis S, Stratoulias Y, Papadopoulou G, Kriebardis AG, Samiotaki M, Vekrellis K. Aging Dis. 2024 Apr 1;15(2):869-892.
  22. Red Blood Cell Metabolism In Vivo and In Vitro. D’Alessandro A, Anastasiadi AT, Tzounakas VL, Nemkov T, Reisz JA, Kriebardis AG, Zimring JC, Spitalnik SL, Busch MP. Metabolites. 2023 Jun 27;13(7):793.
  23. Differential intracellular trafficking of extracellular vesicles in microglia and astrocytes. Pantazopoulou M, Lamprokostopoulou A, Karampela DS, Alexaki A, Delis A, Coens A, Samiotaki M, Kriebardis AG, Melki R, Pagakis SN, Stefanis L, Vekrellis K. Cell Mol Life Sci. 2023 Jun 30;80(7):193.
  24. The time-course linkage between hemolysis, redox, and metabolic parameters during red blood cell storage with or without uric acid and ascorbic acid supplementation. Anastasiadi AT, Stamoulis K, Papageorgiou EG, Lelli V, Rinalducci S, Papassideri IS, Kriebardis AG, Antonelou MH, Tzounakas VL. Front Aging. 2023 Mar 21;4:1161565.
  25. Benefits of hypoxic storage of red blood cells. Kriebardis AG. Blood Transfus. 2023 Jan;21(1):1-2.
  26. The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH-Future Horizons in NASH Management. Trifylli EM, Kriebardis AG, Koustas E, Papadopoulos N, Deutsch M, Aloizos G, Fortis SP, Papageorgiou EG, Tsagarakis A, Manolakopoulos S. Int J Mol Sci. 2022 Oct 12;23(20):12185.
  27. Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review. Tsalas S, Petrou E, Tsantes AG, Sokou R, Loukopoulou E, Houhoula D, Mantzios PG, Kriebardis AG, Tsantes AE. Semin Thromb Hemost. 2023 Jul;49(5):523-541.
  28. The impact of maternal smoking during pregnancy on hemostatic profile of neonates using thromboelastometry (ROTEM). A pilot observational study. Sokou R, Konstantinidi A, Tsante KA, Tsantes AG, Parastatidou S, Ioakeimidis G, Lampridou M, Frantzeskaki F, Houhoula D, Kriebardis AG, Piovani D, Bonovas S, Iacovidou N, Tsantes AE. Placenta. 2022 Nov;129:23-29.
  29. Supplementation with uric and ascorbic acid protects stored red blood cells through enhancement of non-enzymatic antioxidant activity and metabolic rewiring. Tzounakas VL, Anastasiadi AT, Arvaniti VZ, Lelli V, Fanelli G, Paronis EC, Apostolidou AC, Balafas EG, Kostomitsopoulos NG, Papageorgiou EG, Papassideri IS, Stamoulis K, Kriebardis AG, Rinalducci S, Antonelou MH. Redox Biol. 2022 Nov;57:102477.
  30. Rotational Thromboelastometry Predicts Transfusion Requirements in Total Joint Arthroplasties. Tsantes AG, Papadopoulos DV, Roustemis AG, Trikoupis IG, Piovani D, Tsante KA, Mantzios PG, Mavrogenis AF, Sokou R, Kokoris SI, Kriebardis AG, Papagelopoulos PJ, Bonovas S, Tsantes AE. Semin Thromb Hemost. 2023 Mar;49(2):134-144.
  31. The Utility of NATEM Assay in Predicting Bleeding Risk in Critically Ill Neonates. Sokou R, Georgiadou P, Tsantes AG, Parastatidou S, Konstantinidi A, Ioakeimidis G, Makrogianni A, Theodoraki M, Kokoris S, Iacovidou N, Kriebardis AG, Piovani D, Bonovas S, Tsantes AE. Semin Thromb Hemost. 2023 Mar;49(2):182-191.
  32. The Hypercoagulable Profile of Patients with Bone Tumors: A Pilot Observational Study Using Rotational Thromboelastometry. Tsantes AG, Loukopoulou I, Papadopoulos DV, Trikoupis IG, Roustemis AG, Goumenos S, Sokou R, Tsante KA, Kriebardis AG, Koulouvaris P, Houhoula D, Piovani D, Papagelopoulos PJ, Bonovas S, Tsantes AE. Cancers (Basel). 2022 Aug 15;14(16):3930.
  33. In Sickness and in Health: Erythrocyte Responses to Stress and Aging. Antonelou MH, D’Alessandro A, Kriebardis AG. Int J Mol Sci. 2022 Jun 23;23(13):6957.
  34. Innate Variability in Physiological and Omics Aspects of the Beta Thalassemia Trait-Specific Donor Variation Effects. Anastasiadi AT, Tzounakas VL, Dzieciatkowska M, Arvaniti VZ, Papageorgiou EG, Papassideri IS, Stamoulis K, D’Alessandro A, Kriebardis AG, Antonelou MH. Front Physiol. 2022 Jun 8;13:907444.
  35. Blood Cell-Derived Microvesicles in Hematological Diseases and beyond. Georgatzakou HT, Fortis SP, Papageorgiou EG, Antonelou MH, Kriebardis AG. 2022 Jun 8;12(6):803.
  36. Early and Late-Phase 24 h Responses of Stored Red Blood Cells to Recipient-Mimicking Conditions. Tzounakas VL, Anastasiadi AT, Karadimas DG, Velentzas AD, Anastasopoulou VI, Papageorgiou EG, Stamoulis K, Papassideri IS, Kriebardis AG, Antonelou MH. Front Physiol. 2022 Jun 1;13:907497.
  37. Assessment of agreement between EXTEM and NATEM thromboelastometry measurement assays in critically ill neonates. Tsantes AG, Konstantinidi A, Parastatidou S, Ioakeimidis G, Tsante KA, Mantzios PG, Kriebardis AG, Gialeraki A, Houhoula D, Iacovidou N, Piovani D, Bonovas S, Tsantes AE, Sokou R. Eur J Haematol. 2022 Oct;109(4):327-335.
  38. Economic crisis in Greece: The invisible enemy of blood donation or not? Fortis SP, Kriebardis AG, Georgatzakou HT, Lyrakos G, Alexiou P, Antoniou C, Papadopoulos G, Stamoulis KE, Valsami S. Transfus Apher Sci. 2022 Dec;61(6):103467.
  39. Corpuscular Fragility and Metabolic Aspects of Freshly Drawn Beta-Thalassemia Minor RBCs Impact Their Physiology and Performance Post Transfusion: A Triangular Correlation Analysis In Vitro and In Vivo. Anastasiadi AT, Arvaniti VZ, Paronis EC, Kostomitsopoulos NG, Stamoulis K, Papassideri IS, D’Alessandro A, Kriebardis AG, Tzounakas VL, Antonelou MH. Biomedicines. 2022 Feb 23;10(3):530.
  40. Deciphering the Relationship Between Free and Vesicular Hemoglobin in Stored Red Blood Cell Units. Tzounakas VL, Anastasiadi AT, Lekka ME, Papageorgiou EG, Stamoulis K, Papassideri IS, Kriebardis AG, Antonelou MH. Front Physiol. 2022 Feb 8;13:840995.
  41. Red Blood Cell Abnormalities as the Mirror of SARS-CoV-2 Disease Severity: A Pilot Study. Bouchla A, Kriebardis AG, Georgatzakou HT, Fortis SP, Thomopoulos TP, Lekkakou L, Markakis K, Gkotzias D, Panagiotou A, Papageorgiou EG, Pouliakis A, Stamoulis KE, Papageorgiou SG, Pappa V, Valsami S. Front Physiol. 2022 Jan 20;12:825055.
  42. The Post-Storage Performance of RBCs from Beta-Thalassemia Trait Donors Is Related to Their Storability Profile. Anastasiadi AT, Paronis EC, Arvaniti VZ, Velentzas AD, Apostolidou AC, Balafas EG, Dzieciatkowska M, Kostomitsopoulos NG, Stamoulis K, Papassideri IS, D’Alessandro A, Kriebardis AG, Antonelou MH, Tzounakas VL. Int J Mol Sci. 2021 Nov 13;22(22):12281.
  43. Thromboelastometry in Neonates with Respiratory Distress Syndrome: A Pilot Study. Katsaras GN, Sokou R, Tsantes AG, Konstantinidi A, Gialamprinou D, Piovani D, Bonovas S, Kriebardis AG, Mitsiakos G, Kokoris S, Tsantes AE. Diagnostics (Basel). 2021 Oct 27;11(11):1995.
  44. The Importance of Use of the On-line Databases as a Source for Systematic Review of Toxoplasmosis Screening During Pregnancy. Voyiatzaki C, Orovas C, Trapali M, Chaniotis DI, Kriebardis AG, Beloukas A, Thalassinos ND, Orovou E, Iatrakis G, Antoniou E. Acta Inform Med. 2021 Sep;29(3):216-223.
  45. Coagulation Abnormalities in Renal Pathology of Chronic Kidney Disease: The Interplay between Blood Cells and Soluble Factors. Pavlou EG, Georgatzakou HT, Fortis SP, Tsante KA, Tsantes AG, Nomikou EG, Kapota AI, Petras DI, Venetikou MS, Papageorgiou EG, Antonelou MH, Kriebardis AG. 2021 Sep 4;11(9):1309.
  46. Red Blood Cell Proteasome in Beta-Thalassemia Trait: Topology of Activity and Networking in Blood Bank Conditions. Anastasiadi AT, Tzounakas VL, Arvaniti VZ, Dzieciatkowska M, Stamoulis K, Lekka ME, Papassideri IS, D’Alessandro A, Kriebardis AG, Antonelou MH. Membranes (Basel). 2021 Sep 17;11(9):716.
  47. Osmotic hemolysis is a donor-specific feature of red blood cells under various storage conditions and genetic backgrounds. Tzounakas VL, Anastasiadi AT, Valsami SI, Stamoulis KE, Papageorgiou EG, Politou M, Papassideri IS, Kriebardis AG, Antonelou MH. Transfusion. 2021 Sep;61(9):2538-2544.
  48. Rotational Thromboelastometry in Neonates Admitted to a Neonatal Intensive Care Unit: A Large Cross-sectional Study. Sokou R, Tsantes AG, Konstantinidi A, Ioakeimidis G, Lampridou M, Parastatidou S, Theodoraki M, Piovani D, Iliodromiti Z, Boutsikou T, Iacovidou N, Douramani P, Poulis A, Kokoris S, Kriebardis AG, Bonovas S, Tsantes AE. Semin Thromb Hemost. 2021 Oct;47(7):875-884.
  49. Rotational Thromboelastometry Findings are Associated with Symptomatic Venous Thromboembolic Complications after Hip Fracture Surgery.Tsantes AG, Papadopoulos DV, Trikoupis IG, Tsante KA, Mavrogenis AF, Koulouvaris P, Piovani D, Kriebardis AG, Gialeraki A, Nikolopoulos GK, Bonovas S, Papagelopoulos PJ, Tsantes AE. Clin Orthop Relat Res. 2021 Nov 1;479(11):2457-2467.
  50. Haemostatic profile of riboflavin-treated apheresis platelet concentrates. Petrou E, Nikolopoulos GK, Kriebardis AG, Pantavou K, Loukopoulou E, Tsantes AG, Georgatzakou HT, Maratou E, Rapti E, Mellou S, Kokoris S, Gialeraki A, Tsantes AE. Blood Transfus. 2022 May;20(3):223-234.
  51. Leukoreduction makes a difference: A pair proteomics study of extracellular vesicles in red blood cell units. Tzounakas VL, Stamoulis KE, Anastasiadi AT, Papassideri IS, Kriebardis AG, Rinalducci S, Antonelou MH. Transfus Apher Sci. 2021 Jun;60(3):103166.
  52. Fatty acid desaturase activity in mature red blood cells and implications for blood storage quality. Thomas T, Cendali F, Fu X, Gamboni F, Morrison EJ, Beirne J, Nemkov T, Antonelou MH, Kriebardis AG, Welsby I, Hay A, Dziewulska KH, Busch MP, Kleinman S, Buehler PW, Spitalnik SL, Zimring JC, D’Alessandro A. Transfusion. 2021 Jun;61(6):1867-1883.
  53. Proteome of Stored RBC Membrane and Vesicles from Heterozygous Beta Thalassemia Donors. Tzounakas VL, Anastasiadi AT, Dzieciatkowska M, Karadimas DG, Stamoulis K, Papassideri IS, Hansen KC, D’Alessandro A, Kriebardis AG, Antonelou MH. Int J Mol Sci. 2021 Mar 25;22(7):3369.
  54. Beta thalassemia minor is a beneficial determinant of red blood cell storage lesion. Tzounakas VL, Anastasiadi AT, Stefanoni D, Cendali F, Bertolone L, Gamboni F, Dzieciatkowska M, Rousakis P, Vergaki A, Soulakis V, Tsitsilonis OE, Stamoulis K, Papassideri IS, Kriebardis AG, D’Alessandro A, Antonelou MH. Haematologica. 2022 Jan 1;107(1):112-125.
  55. Reply to Ghirardello et al Letter to the Editor. Sokou R, Piovani D, Konstantinidi A, Tsantes AG, Parastatidou S, Lampridou M, Ioakeimidis G, Gounaris A, Iacovidou N, Kriebardis AG, Politou M, Kopterides P, Bonovas S, Tsantes AE. Thromb Haemost. 2021 Aug;121(8):1119-1120.
  56. Red cell proteasome modulation by storage, redox metabolism and transfusion. Tzounakas VL, Dzieciatkowska M, Anastasiadi AT, Karadimas DG, Vergaki A, Siourounis P, Stamoulis K, Papassideri IS, Kriebardis AG, D’Alessandro A, Antonelou MH. Blood Transfus. 2022 Jan;20(1):27-39.
  57. Higher coagulation activity in hip fracture patients: A case-control study using rotational thromboelastometry. Tsantes AG, Trikoupis IG, Papadopoulos DV, Tsante KA, Mavrogenis AF, Koulouvaris P, Savvidou OD, Kontogeorgakos VA, Piovani D, Kriebardis AG, Bonovas S, Papagelopoulos PJ, Tsantes AE. Int J Lab Hematol. 2021 Jun;43(3):477-484.
  58. Sex-related aspects of the red blood cell storage lesion. Tzounakas VL, Anastasiadi AT, Drossos PV, Karadimas DG, Valsami SÉ, Stamoulis KE, Papassideri IS, Politou M, Antonelou MH, Kriebardis AG. Blood Transfus. 2021 May;19(3):224-236.
  59. .A Risk Score for Predicting the Incidence of Hemorrhage in Critically Ill Neonates: Development and Validation Study. Sokou R, Piovani D, Konstantinidi A, Tsantes AG, Parastatidou S, Lampridou M, Ioakeimidis G, Gounaris A, Iacovidou N, Kriebardis AG, Politou M, Kopterides P, Bonovas S, Tsantes AE. Thromb Haemost. 2021 Feb;121(2):131-139.
  60. When I need you most: frozen red blood cells for transfusion. Anastasiadi AT, Tzounakas VL, Kriebardis AG, Stamoulis KE, Seghatchian J, Antonelou MH. Transfus Apher Sci. 2020 Jun;59(3):102786.
  61. The Multi-Faced Extracellular Vesicles in the Plasma of Chronic Kidney Disease Patients. Georgatzakou HT, Pavlou EG, Papageorgiou EG, Papassideri IS, Kriebardis AG, Antonelou MH. Front Cell Dev Biol. 2020 Apr 15;8:227.
  62. “Valar morghulis": all red cells must die. Georgatzakou HT, Antonelou MH, Papageorgiou EG, Kriebardis AG. Blood Transfus. 2020 Mar;18(2):83-85.
  63. Plasma signature of apoptotic microvesicles is associated with endothelial dysfunction and plaque rupture in acute coronary syndromes. Zacharia E, Antonopoulos AS, Oikonomou E, Papageorgiou N, Pallantza Z, Miliou A, Mystakidi VC, Simantiris S, Kriebardis AG, Orologas N, Valasiadi E, Papaioannou S, Galiatsatos N, Antoniades C, Tousoulis D. J Mol Cell Cardiol. 2020 Jan;138:110-114.
  64. Recipient’s effects on stored red blood cell performance: the case of uremic plasma. Georgatzakou HT, Tzounakas VL, Velentzas AD, Papassideri IS, Kokkalis AC, Stamoulis KE, Kriebardis AG, Antonelou MH. Transfusion. 2019 Jun;59(6):1900-1906.
  65. Red cell transfusion in paediatric patients with thalassaemia and sickle cell disease: Current status, challenges and perspectives. Tzounakas VL, Valsami SI, Kriebardis AG, Papassideri IS, Seghatchian J, Antonelou MH. Transfus Apher Sci. 2018 Jun;57(3):347-357.
  66. Redox Status, Procoagulant Activity, and Metabolome of Fresh Frozen Plasma in Glucose 6-Phosphate Dehydrogenase Deficiency. Tzounakas VL, Gevi F, Georgatzakou HT, Zolla L, Papassideri IS, Kriebardis AG, Rinalducci S, Antonelou MH. Front Med (Lausanne). 2018 Feb 5;5:16.
  67. Metabolic Linkage and Correlations to Storage Capacity in Erythrocytes from Glucose 6-Phosphate Dehydrogenase-Deficient Donors. Reisz JA, Tzounakas VL, Nemkov T, Voulgaridou AI, Papassideri IS, Kriebardis AG, D’Alessandro A, Antonelou MH. Front Med (Lausanne). 2018 Jan 11;4:248.
  68. Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage. Nemkov T, Sun K, Reisz JA, Song A, Yoshida T, Dunham A, Wither MJ, Francis RO, Roach RC, Dzieciatkowska M, Rogers SC, Doctor A, Kriebardis AG, Antonelou M, Papassideri I, Young CT, Thomas TA, Hansen KC, Spitalnik SL, Xia Y, Zimring JC, Hod EA, D’Alessandro A. Haematologica. 2018 Feb;103(2):361-372.
  69. Donor-specific individuality of red blood cell performance during storage is partly a function of serum uric acid levels. Tzounakas VL, Karadimas DG, Anastasiadi AT, Georgatzakou HT, Kazepidou E, Moschovas D, Velentzas AD, Kriebardis AG, Zafeiropoulos NE, Avgeropoulos A, Lekka M, Stamoulis KE, Papassideri IS, Antonelou MH. Transfusion. 2018 Jan;58(1):34-40.
  70. Short-term effects of hemodiafiltration versus conventional hemodialysis on erythrocyte performance. Georgatzakou HT, Tzounakas VL, Kriebardis AG, Velentzas AD, Kokkalis AC, Antonelou MH, Papassideri IS. Can J Physiol Pharmacol. 2018 Mar;96(3):249-257.
  71. Temperature-dependent haemolytic propensity of CPDA-1 stored red blood cells vs whole blood – Red cell fragility as donor signature on blood units. Tzounakas VL, Anastasiadi AT, Karadimas DG, Zeqo RA, Georgatzakou HT, Pappa OD, Papatzitze OA, Stamoulis KE, Papassideri IS, Antonelou MH, Kriebardis AG. Blood Transfus. 2017 Sep;15(5):447-455.
  72. Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy. Georgatzakou HT, Tzounakas VL, Kriebardis AG, Velentzas AD, Papageorgiou EG, Voulgaridou AI, Kokkalis AC, Antonelou MH, Papassideri IS. Eur J Haematol. 2017 Jun;98(6):590-600.
  73. Unraveling the Gordian knot: red blood cell storage lesion and transfusion outcomes. Tzounakas VL, Kriebardis AG, Seghatchian J, Papassideri IS, Antonelou MH. Blood Transfus. 2017 Mar;15(2):126-130.
  74. Data on how several physiological parameters of stored red blood cells are similar in glucose 6-phosphate dehydrogenase deficient and sufficient donors. Tzounakas VL, Kriebardis AG, Georgatzakou HT, Foudoulaki-Paparizos LE, Dzieciatkowska M, Wither MJ, Nemkov T, Hansen KC, Papassideri IS, D’Alessandro A, Antonelou MH. Data Brief. 2016 Jun 23;8:618-27.
  75. Microparticles variability in fresh frozen plasma: preparation protocol and storage time effects. Kriebardis AG, Antonelou MH, Georgatzakou HT, Tzounakas VL, Stamoulis KE, Papassideri IS. Blood Transfus. 2016 May;14(2):228-37.
  76. Donor-variation effect on red blood cell storage lesion: A close relationship emerges. Tzounakas VL, Kriebardis AG, Papassideri IS, Antonelou MH. Proteomics Clin Appl. 2016 Aug;10(8):791-804.
  77. Glucose 6-phosphate dehydrogenase deficient subjects may be better “storers" than donors of red blood cells. Tzounakas VL, Kriebardis AG, Georgatzakou HT, Foudoulaki-Paparizos LE, Dzieciatkowska M, Wither MJ, Nemkov T, Hansen KC, Papassideri IS, D’Alessandro A, Antonelou MH. Free Radic Biol Med. 2016 Jul;96:152-65.
  78. Donor variation effect on red blood cell storage lesion: a multivariable, yet consistent, story. Tzounakas VL, Georgatzakou HT, Kriebardis AG, Voulgaridou AI, Stamoulis KE, Foudoulaki-Paparizos LE, Antonelou MH, Papassideri IS. Transfusion. 2016 Jun;56(6):1274-86.
  79. Red blood cell abnormalities and the pathogenesis of anemia in end-stage renal disease. Georgatzakou HT, Antonelou MH, Papassideri IS, Kriebardis AG. Proteomics Clin Appl. 2016 Aug;10(8):778-90.
  80. Immunohistochemical determination of the extracellular matrix modulation in a rat model of choline-deprived myocardium: the effects of carnitine. Strilakou A, Perelas A, Lazaris A, Papavdi A, Karkalousos P, Giannopoulou I, Kriebardis AG, Panayiotides I, Liapi C. Fundam Clin Pharmacol. 2016 Feb;30(1):47-57.
  81. Uric acid variation among regular blood donors is indicative of red blood cell susceptibility to storage lesion markers: A new hypothesis tested. Tzounakas VL, Georgatzakou HT, Kriebardis AG, Papageorgiou EG, Stamoulis KE, Foudoulaki-Paparizos LE, Antonelou MH, Papassideri IS. Transfusion. 2015 Nov;55(11):2659-71.
  82. An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies. D’Alessandro A, Kriebardis AG, Rinalducci S, Antonelou MH, Hansen KC, Papassideri IS, Zolla L. Transfusion. 2015 Jan;55(1):205-19.
  83. With or without you: a tale about oxygen removal from stored, packed erythrocytes. Kriebardis AG. Blood Transfus. 2014 Oct;12(4):449-51.
  84. Attitudes and behaviours of Greeks concerning blood donation: recruitment and retention campaigns should be focused on need rather than altruism. Kalargirou AA, Beloukas AI, Kosma AG, Nanou CI, Saridi MI, Kriebardis AG. Blood Transfus. 2014 Jul;12(3):320-9.
  85. Appropriate utilization of restricted antibiotics in a general hospital of a perfecture area in Greece. Saridi M, Rekleiti M, Toska A, Kriebardis AG, Tsironi M, Syrigos K, Souliotis K. Curr Drug Saf. 2014;9(3):212-9.
  86. Blood modifications associated with end stage renal disease duration, progression and cardiovascular mortality: a 3-year follow-up pilot study. Antonelou MH, Georgatzakou HT, Tzounakas VL, Velentzas AD, Kokkalis AC, Kriebardis AG, Papassideri IS. J Proteomics. 2014 Apr 14;101:88-101.
  87. Knowledge about umbilical cord blood banking among Greek citizens. Karagiorgou LZ, Pantazopoulou MN, Mainas NC, Beloukas AI, Kriebardis AG. Blood Transfus. 2014 Jan;12 Suppl 1(Suppl 1):s353-60.
  88. Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions? Kriebardis AG, Antonelou M, Stamoulis K, Papassideri I. Blood Transfus. 2012 May;10 Suppl 2(Suppl 2):s25-38.
  89. Effects of pre-storage leukoreduction on stored red blood cells signaling: a time-course evaluation from shape to proteome. Antonelou MH, Tzounakas VL, Velentzas AD, Stamoulis KE, Kriebardis AG, Papassideri IS. J Proteomics. 2012 Dec 5;76 Spec No.:220-38.
  90. Apolipoprotein J/clusterin in human erythrocytes is involved in the molecular process of defected material disposal during vesiculation. Antonelou MH, Kriebardis AG, Stamoulis KE, Trougakos IP, Papassideri IS. PLoS One. 2011;6(10):e26033.
  91. Apolipoprotein J/Clusterin is a novel structural component of human erythrocytes and a biomarker of cellular stress and senescence. Antonelou MH, Kriebardis AG, Stamoulis KE, Trougakos IP, Papassideri IS. PLoS One. 2011;6(10):e26032.
  92. Oxidative stress-associated shape transformation and membrane proteome remodeling in erythrocytes of end stage renal disease patients on hemodialysis. Antonelou MH, Kriebardis AG, Velentzas AD, Kokkalis AC, Georgakopoulou SC, Papassideri IS. J Proteomics. 2011 Oct 19;74(11):2441-52.
  93. Aging and death signalling in mature red cells: from basic science to transfusion practice. Antonelou MH, Kriebardis AG, Papassideri IS. Blood Transfus. 2010 Jun;8 Suppl 3(Suppl 3):s39-47.
  94. Red blood cell aging markers during storage in citrate-phosphate-dextrose-saline-adenine-glucose-mannitol. Antonelou MH, Kriebardis AG, Stamoulis KE, Economou-Petersen E, Margaritis LH, Papassideri IS. Transfusion. 2010 Feb;50(2):376-89.
  95. RBC-derived vesicles during storage: ultrastructure, protein composition, oxidation, and signaling components. Kriebardis AG, Antonelou MH, Stamoulis KE, Economou-Petersen E, Margaritis LH, Papassideri IS. Transfusion. 2008 Sep;48(9):1943-53.
  96. Storage-dependent remodeling of the red blood cell membrane is associated with increased immunoglobulin G binding, lipid raft rearrangement, and caspase activation. Kriebardis AG, Antonelou MH, Stamoulis KE, Economou-Petersen E, Margaritis LH, Papassideri IS. Transfusion. 2007 Jul;47(7):1212-20.
  97. Progressive oxidation of cytoskeletal proteins and accumulation of denatured hemoglobin in stored red cells. Kriebardis AG, Antonelou MH, Stamoulis KE, Economou-Petersen E, Margaritis LH, Papassideri IS. J Cell Mol Med. 2007 Jan-Feb;11(1):148-55.
  98. Membrane protein carbonylation in non-leukodepleted CPDA-preserved red blood cells. Kriebardis AG, Antonelou MH, Stamoulis KE, Economou-Petersen E, Margaritis LH, Papassideri IS.Blood Cells Mol Dis. 2006 Mar-Apr;36(2):279-82.